Live Breaking News & Updates on Biocryst Pharmaceuticals Chart

Stay updated with breaking news from Biocryst pharmaceuticals chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO (berotralstat) Treatment

23.02.2024 - RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2024 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new analyses of real-world use of oral, once-daily ORLADEYO (berotralstat) that showed patients who initiated ORLADEYO . Seite 1 ....

United States , Bryan Arnold , Jonathan Bernstein , Bernstein Clinical Research Center , University Of Cincinnati , Bernstein Allergy Group , Bernstein Clinical Research , Rate Reduction After Beginning , Multiple Patient , Biocryst Pharmaceuticals Chart , Iocryst Pharmaceuticals Kurs , Iocryst Pharmaceuticals Aktie ,

BioCryst to Present at Upcoming Investor Conferences

21.02.2024 - RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2024 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the TD Cowen 44th Annual Health Care Conference in Boston on Wednesday, March 6, 2024, at . ....

United States , Biocryst Pharmaceuticals Inc , Health Care Conference , Cryst Pharmaceuticals , Annual Health Care Conference , Annual Global Healthcare Conference , Biocryst Pharmaceuticals Chart , Iocryst Pharmaceuticals Kurs , Iocryst Pharmaceuticals Aktie ,

BioCryst Launches ORLADEYO (berotralstat) in Italy

19.02.2024 - RESEARCH TRIANGLE PARK, N.C., Feb. 19, 2024 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA), has finalized reimbursement and recommended . ....

Charlie Gayer , Biocryst Pharmaceuticals Inc , Italian Medicines Agency , Cryst Pharmaceuticals , Agenzia Italiana Del Farmaco , Biocryst Pharmaceuticals Chart , Iocryst Pharmaceuticals Kurs , Iocryst Pharmaceuticals Aktie ,

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02.02.2024 - RESEARCH TRIANGLE PARK, N.C., Feb. 02, 2024 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted nine newly-hired employees stock options to . ....

Biocryst Pharmaceuticals Inc , Cryst Pharmaceuticals , Nasdaq Listing Rule , Inducement Equity Incentive Plan , Biocryst Pharmaceuticals Chart , Iocryst Pharmaceuticals Kurs , Iocryst Pharmaceuticals Aktie ,

BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside's Proprietary SCS Microinjector Seite 1

03.11.2023 - – SCS Microinjector is the first and only FDA-approved approach to access the suprachoroidal space – – BioCryst to host R&D Day today at 1:00 pm ET – ALPHARETTA, Ga. and RESEARCH TRIANGLE PARK, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) - . Seite 1 ....

Jon Stonehouse , George Lasezkay , Clearside Biomedical Inc , Biocryst Pharmaceuticals Inc , Cryst Pharmaceuticals , Clearside Biomedical , Biocryst Pharmaceuticals Chart , Iocryst Pharmaceuticals Kurs , Iocryst Pharmaceuticals Aktie ,